Related Experiment Video

Updated: Aug 14, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

ERBB2 kinase domain mutation in a gastric cancer metastasis

Jong Woo Lee1, Young Hwa Soung, Su Young Kim

  • 1Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul.

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|November 29, 2005
PubMed

Insights

ERBB2 gene mutations in the kinase domain were found in metastatic gastric cancer. This suggests ERBB2 mutations may contribute to cancer spread, offering new insights into gastric cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • ERBB2 (Erb-B2 receptor tyrosine kinase 2) is part of the epidermal growth factor receptor (EGFR) family.
  • Mutations in the ERBB2 kinase domain are implicated in various human cancers, including gastric cancer.
  • The role of ERBB2 kinase domain mutations in cancer metastasis remains largely unexplored.

Purpose of the Study:

  • To investigate the potential involvement of ERBB2 kinase domain mutations in the mechanism of gastric cancer metastasis.
  • To detect somatic mutations within the ERBB2 kinase domain in gastric adenocarcinomas exhibiting lymph node metastasis.

Main Methods:

  • Analysis of the ERBB2 kinase domain for somatic mutations in 58 gastric adenocarcinomas with lymph node metastasis.
  • Identification of a specific missense mutation (V832I) in exon 21 of ERBB2.
  • Simultaneous analysis of EGFR, K-RAS, PIK3CA, and BRAF gene mutations in the identified sample.

Main Results:

  • One ERBB2 mutation (V832I missense mutation) was detected exclusively in lymph node metastasis, not in the primary tumor of the same patient.
  • The identified metastatic carcinoma did not harbor mutations in EGFR, K-RAS, PIK3CA, or BRAF.
  • This finding indicates ERBB2 kinase domain mutations can occur in metastatic gastric carcinoma.

Conclusions:

  • ERBB2 kinase domain mutations are occasionally present in metastatic gastric carcinoma.
  • These mutations may play a role in the metastatic process of a subset of gastric cancers.
  • Further research is warranted to elucidate the precise role of ERBB2 mutations in gastric cancer metastasis.

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...